Zinc in skin pathology and care

References

• Raulin J. Etudes cliniques sur la vegetation. Ann Sci Nat Bot Biol Veg 1869; 11((93))
   Google Scholar
• Coleman J. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 1992; 61: 897–946
   PubMed Web of Science ®Google Scholar
• Prasad A. Zinc and enzymes. Plenum Press, New York 1993
   Google Scholar
• Prasad A. Zinc and gene expression, , et al. Plenum Press, New York 1993
   Google Scholar
• Hernick M., Fierke C. Zinc hydrolases: the mechanisms of zinc‐dependent deacetylases. Arch Biochem Biophys 2005; 433: 71–84
   PubMed Web of Science ®Google Scholar
• Vallee B., Falchuk K. The biochemical basis of zinc physiology. Physiol Rev 1993; 73: 79–118
   PubMed Web of Science ®Google Scholar
• Prasad A. Zinc deficiency. BMJ 2003; 326: 409–10
   PubMed Web of Science ®Google Scholar
• King J., Shames D., Woodhouse L. Zinc homeostasis in humans. J Nutr 2000; 130((5S suppl))1360S–6S
   Google Scholar
• Murphy E., Willis B., Watt B. Provisional tables on the zinc content of foods. J Am Diet Assoc 1975; 66: 345–55
   PubMed Web of Science ®Google Scholar
• Hunt J. Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am J Clin Nutr 2003; 78((3 suppl))633S–9S
   Google Scholar
• Krebs N. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 2000; 130((5S suppl))1374S–7S
   Google Scholar
• Prasad A., Halsted J., Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. Am J Med 1961; 31: 532–46
   PubMed Web of Science ®Google Scholar
• Prasad A. Zinc in growth and development and spectrum of human zinc deficiency. J Am Coll Nutr 1988; 7: 377–84
   PubMed Web of Science ®Google Scholar
• Gibson R. Zinc nutrition in developing countries. Nutr Res Rev 1994; 7: 151–73
   PubMedGoogle Scholar
• Prasad A., Miale Jr A., Farid Z., Sandstead H., Schulert A. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypogonadism. J Lab Clin Med 1963; 61: 537–49
   PubMed Web of Science ®Google Scholar
• Sandstead H., Prasad A., Schulert A., et al. Human zinc deficiency, endocrine manifestations and response to treatment. Am J Clin Nutr 1967; 20: 422–42
   PubMed Web of Science ®Google Scholar
• Danbolt N., Closs K. Akrodermatitis enteropathica. Acta Derm Venereol 1942; 23: 127–69
   Google Scholar
• Barnes P., Moynahan E. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerance treated with synthetic diet. Proc R Soc Med 1973; 66: 327–9
   PubMedGoogle Scholar
• Michaëlsson G. Zinc therapy in acrodermatitis enteropathica. Acta Derm Venereol 1974; 54: 377–81
   PubMed Web of Science ®Google Scholar
• Kury S., Dreno B., Bezieau S., et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002; 31: 239–40
   PubMed Web of Science ®Google Scholar
• Perafan‐Riveros C., Franca L., Alves A., Sanches J Jr. Acrodermatitis enteropathica: case report and review of the literature. Pediatr Dermatol 2002; 19: 426–31
   Web of Science ®Google Scholar
• Kay R., Tasman‐Jones C., Pybus J., Whiting R., Black H. A syndrome of acute zinc deficiency during total parenteral alimentation in man. Ann Surg 1976; 183: 331–40
   PubMed Web of Science ®Google Scholar
• Fitzherbert J. Zinc deficiency in acne vulgaris. Med J Aust 1977; 2((20))685–6
   Google Scholar
• Amer M., Bahgat M., Tosson Z., Abdel Mowla M., Amer K. Serum zinc in acne vulgaris. Int J Dermatol 1982; 21: 481–4
   PubMed Web of Science ®Google Scholar
• Michaëlsson G., Vahlquist A., Juhlin L. Serum zinc and retinol‐binding protein in acne. Br J Dermatol 1977; 96: 283–6
   PubMed Web of Science ®Google Scholar
• Michaëlsson G., Juhlin L., Vahlquist A. Effects of oral zinc and vitamin A in acne. Arch Dermatol 1977; 113: 31–6
   PubMed Web of Science ®Google Scholar
• Hillstrom L., Pettersson L., Hellbe L., Kjellin A., Leczinsky C., Nordwall C. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol 1977; 97: 681–4
   PubMed Web of Science ®Google Scholar
• Göransson K., Liden S., Odsell L. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Derm Venereol 1978; 58: 443–8
   PubMed Web of Science ®Google Scholar
• Verma K., Saini A., Dhamija S. Oral zinc sulphate therapy in acne vulgaris: a double‐blind trial. Acta Derm Venereol 1980; 60: 337–40
   PubMed Web of Science ®Google Scholar
• Liden S., Goransson K., Odsell L. Clinical evaluation in acne. Acta Derm Venereol Suppl (Stockh) 1980; Suppl 89: 47–52
   Google Scholar
• Orris L., Shalita A., Sibulkin D., London S., Gans E. Oral zinc therapy of acne. Absorption and clinical effect. Arch Dermatol 1978; 114: 1018–20
   Google Scholar
• Weimar V., Puhl S., Smith W., tenBroeke J. Zinc sulfate in acne vulgaris. Arch Dermatol 1978; 114: 1776–8
   PubMed Web of Science ®Google Scholar
• Cunliffe W. Unacceptable side‐effects of oral zinc sulphate in the treatment of acne vulgaris. Br J Dermatol 1979; 101: 363
   Google Scholar
• Dreno B., Amblard P., Agache P., Sirot S., Litoux P. Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol Suppl (Stockh) 1989; 69: 541–3
   Google Scholar
• Dreno B., Moyse D., Alirezai M., et al. Acne Research and Study Group. Multicenter randomized comparative double‐blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001; 203: 135–40
   PubMed Web of Science ®Google Scholar
• Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol 2000; 10: 269–73
   PubMed Web of Science ®Google Scholar
• Michaëlsson G., Juhlin L., Ljunghall K. A double‐blind study of the effect of zinc and oxytetracycline in acne vulgaris. Br J Dermatol 1977; 97: 561–6
   PubMed Web of Science ®Google Scholar
• Feucht C., Allen B., Chalker D., Smith J. J. Topical erythromycin with zinc in acne. A double‐blind controlled study. J Am Acad Dermatol 1980; 3: 483–91
   PubMed Web of Science ®Google Scholar
• Habbema L., Koopmans B., Menke H., Doornweerd S., De Boulle K. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double‐blind comparative study. Br J Dermatol 1989; 121: 497–502
   PubMed Web of Science ®Google Scholar
• Schachner L., Eaglstein W., Kittles C., Mertz P. Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol 1990; 22((2 Pt 1))253–60
   Google Scholar
• Schachner L., Pestana A., Kittles C. A clinical trial comparing the safety and efficacy of a topical erythromycin‐zinc formulation with a topical clindamycin formulation. J Am Acad Dermatol 1990; 22: 489–95
   PubMed Web of Science ®Google Scholar
• Cochran R., Tucker S., Flannigan S. Topical zinc therapy for acne vulgaris. Int J Dermatol 1985; 24: 188–90
   Google Scholar
• Strauss J., Stranieri A. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition. J Am Acad Dermatol 1984; 11: 86–9
   PubMed Web of Science ®Google Scholar
• Toyoda M., Morohashi M. An overview of topical antibiotics for acne treatment. Dermatology 1998; 196: 130–4
   PubMed Web of Science ®Google Scholar
• Bojar R., Eady E., Jones C., Cunliffe W., Holland K. Inhibition of erythromycin‐resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol 1994; 130: 329–36
   PubMed Web of Science ®Google Scholar
• Fluhr J., Bosch B., Gloor M., Hoffler U. In‐vitro and in‐vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin. Zentralbl Bakteriol 1999; 289: 445–56
   PubMedGoogle Scholar
• Rebello T., Atherton D., Holden C. The effect of oral zinc administration on sebum free fatty acids in acne vulgaris. Acta Derm Venereol 1986; 66: 305–10
   Google Scholar
• Dreno B., Trossaert M., Boiteau H., Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol Suppl (Stockh) 1992; 72: 250–2
   Google Scholar
• Pierard G., Pierard‐Franchimont C. Effect of a topical erythromycin‐zinc formulation on sebum delivery. Evaluation by combined photometric‐multi‐step samplings with Sebutape. Clin Exp Dermatol 1993; 18: 410–13
   PubMed Web of Science ®Google Scholar
• Pierard‐Franchimont C., Goffin V., Visser J., Jacoby H., Pierard G. A double‐blind controlled evaluation of the sebosuppressive activity of topical erythromycin–zinc complex. Eur J Clin Pharmacol 1995; 49((1–2))57–60
   Google Scholar
• Van Hoogdalem E., Terpstra I., Baven A. Evaluation of the effect of zinc acetate on the stratum corneum penetration kinetics of erythromycin in healthy male volunteers. Skin Pharmacol 1996; 9: 104–10
   PubMedGoogle Scholar
• Lansdown A. Zinc in the healing wound. Lancet 1996; 347: 706–7
   PubMed Web of Science ®Google Scholar
• Baldwin S., Odio M., Haines S., O'Connor R., Englehart J., Lane A. Skin benefits from continuous topical administration of a zinc oxide/petrolatum formulation by a novel disposable diaper. J Eur Acad Dermatol Venereol 2001; 15((suppl 1))5–11
   Google Scholar
• Arad A., Mimouni D., Ben‐Amitai D., Zeharia A., Mimouni M. Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis. Dermatology 1999; 199: 319–22
   Google Scholar
• Warner R., Schwartz J., Boissy Y., Dawson T. J. Dandruff has an altered stratum corneum ultrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol 2001; 45: 897–903
   PubMed Web of Science ®Google Scholar
• Marks R., Pearse A., Walker A. The effects of a shampoo containing zinc pyrithione on the control of dandruff. Br J Dermatol 1985; 112: 415–22
   PubMed Web of Science ®Google Scholar
• Rapaport M. A randomized, controlled clinical trial of four anti‐dandruff shampoos. J Int Med Res 1981; 9: 152–6
   PubMedGoogle Scholar
• Pierard‐Franchimont C., Goffin V., Decroix J., Pierard G. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol 2002; 15: 434–41
   PubMedGoogle Scholar
• Imokawa G., Okamoto K. The inhibitory effect of zinc pyrithione on the epidermal proliferation of animal skins. Acta Derm Venereol 1982; 62: 471–5
   Google Scholar
• Gibson W., Hardy W., Groom M. The effect and mode of action of zinc pyrithione on cell growth. II. In vivo studies. Food Chem Toxicol 1985; 23: 103–10
   PubMedGoogle Scholar
• Gupte T., Gaikwad U., Naik S. Experimental studies (in vitro) on polyene macrolide antibiotics with special reference to hamycin against Malassezia ovale. Comp Immunol Microbiol Infect Dis 1999; 22: 93–102
   PubMed Web of Science ®Google Scholar
• Schmidt A., Ruhl‐Horster B. In vitro susceptibility of Malassezia furfur. Arzneimittelforschung 1996; 46: 442–4
   Google Scholar
• Berger R., Fu J., Smiles K., et al. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol 2003; 149: 354–62
   PubMed Web of Science ®Google Scholar
• Al‐Gurairi F., Al‐Waiz M., Sharquie K. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo‐controlled clinical trial. Br J Dermatol 2002; 146: 423–31
   PubMed Web of Science ®Google Scholar
• Gibbs S. Zinc sulphate for viral warts. Br J Dermatol 2003; 148: 1082–3
   Google Scholar
• Sharquie K., Najim R., Farjou I., Al‐Timimi D. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001; 26: 21–6
   PubMed Web of Science ®Google Scholar
• Firooz A., Khatami A., Khamesipour A., et al. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double‐blind, controlled clinical trial. J Drugs Dermatol 2005; 4: 73–9
   PubMedGoogle Scholar
• Iraji F., Vali A., Asilian A., Shahtalebi M., Momeni A. Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology 2004; 209: 46–9
   PubMed Web of Science ®Google Scholar
• Sharquie K., Najim R., Farjou I. A comparative controlled trial of intralesionally‐administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol 1997; 22: 169–73
   PubMed Web of Science ®Google Scholar
• Rowlands C., Danby F. Histopathology of psoriasis treated with zinc pyrithione. Am J Dermatopathol 2000; 22: 272–6
   PubMedGoogle Scholar
• Housman T., Keil K., Mellen B., McCarty M., Fleischer A Jr., Feldman S. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol 2003; 49: 79–82
   PubMed Web of Science ®Google Scholar
• Burrows N., Turnbull A., Punchard N., Thompson R., Jones R. A trial of oral zinc supplementation in psoriasis. Cutis 1994; 54: 117–18
   Google Scholar
• Ead R. Oral zinc sulphate in alopacia areata – a double blind trial. Br J Dermatol 1981; 104: 483–4
   Google Scholar
• Rushton D. Nutritional factors and hair loss. Clin Exp Dermatol 2002; 27: 396–404
   PubMedGoogle Scholar
• Rojas A., Phillips T. Patients with chronic leg ulcers show diminished levels of vitamins A and E, carotenes, and zinc. Dermatol Surg 1999; 25: 601–4
   PubMed Web of Science ®Google Scholar
• Ackerman Z., Loewenthal E., Seidenbaum M., Rubinow A., Gorodetsky R. Skin zinc concentrations in patients with varicose ulcers. Int J Dermatol 1990; 29: 360–2
   Google Scholar
• Brandrup F., Menne T., Agren M., Stromberg H., Holst R., Frisen M. A randomized trial of two occlusive dressings in the treatment of leg ulcers. Acta Derm Venereol Suppl (Stockh) 1990; 70: 231–5
   Google Scholar
• Stromberg H., Agren M. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 1984; 111: 461–8
   PubMed Web of Science ®Google Scholar
• Agren M., Stromberg H. Topical treatment of pressure ulcers. A randomized comparative trial of Varidase and zinc oxide. Scand J Plast Reconstr Surg 1985; 19: 97–100
   PubMed Web of Science ®Google Scholar
• Apelqvist J., Larsson J., Stenstrom A. Topical treatment of necrotic foot ulcers in diabetic patients: A comparative trial of DuoDerm and MeZinc. Br J Dermatol 1990; 123: 787–92
   Google Scholar
• Agren M. Studies on zinc in wound healing. Acta Derm Venereol Suppl (Stockh) 1990; 154: 1–36
   PubMedGoogle Scholar
• Wilkinson E., Hawke C. Oral zinc for arterial and venous leg ulcers. Cochrane Database Syst Rev 2000; 2, (CD001273)
   Google Scholar
• Michaëlsson G., Ljunghall K., Danielson B. Zinc in epidermis and dermis in healthy subjects. Acta Derm Venereol 1980; 60: 295–9
   PubMed Web of Science ®Google Scholar
• Michaëlsson G., Ljunghall K. Patients with dermatitis herpetiformis, acne, psoriasis and Darier's disease have low epidermal zinc concentrations. Acta Derm Venereol 1990; 70: 304–8
   PubMed Web of Science ®Google Scholar
• Jain A., Mukherjee A., Chattopadhya D., Saha K. Biometals in skin and sera of leprosy patients and their correlation to trace element contents of M. leprae and histological types of the disease; a comparative study with cutaneous tuberculosis. Int J Lepr Other Mycobact Dis 1995; 63: 249–58
   Google Scholar
• Soderberg T., Hallmans G., Bartholdson L. Treatment of keloids and hypertrophic scars with adhesive zinc tape. Scand J Plast Reconstr Surg 1982; 16: 261–6
   PubMed Web of Science ®Google Scholar
• Agren M. S. Studies on zinc in wound healing. Acta Derm Venereol Suppl (Stockh) 1990; 154: 1–36
   PubMedGoogle Scholar